BioNTech: Between Transformation and Financial Strength BioNTech reported a significant decline in revenue in the second ...

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX), two companies forever linked by their historic COVID-19 vaccine ...

The FDA approved an mRNA seasonal influenza vaccine offering enhanced protection for adults aged 50 years or older compared with standard vaccines. The Conversation — Vaccines have been reliably and ...

An mRNA vaccine, or messenger ribonucleic acid vaccine, is a type of immunization that uses a copy of a molecule called ...

This flu shot, mFlusiva, was shown in a clinical trial to be up to 27 percent more effective than a standard flu jab ...

In a first, the U.S. has approved an influenza vaccine that relies on mRNA technology—the same technology that underpinned ...

One of the beneficial characteristics of the response to the COVID-19 pandemic were pledges from companies involved in developing vaccines (such ...

By Emeka Taye Umezurike Nigeria’s research community received a significant boost in June when the Tertiary Education Trust ...

Q2 2026 earnings call recap: guidance cut, CEO transition, oncology pipeline updates, and key catalysts—read insights and what’s next.

Covid-19 has killed more than a million people in the United States, but in an interview with CNN’s Dana Bash on Sunday, US ...